对喘炎症亚型中介质干细胞的新见解
Zheng-Yan Hou1, Yu-Qiu Hao1, Lin Zhang1
1Department of Respiratory & Critical Care Medicine, Hospital 2, Jilin University, Changchun, China.
Frontiers in immunology
|September 11, 2025
概括
介酶干细胞 (MSC) 和它们的外体细胞 (MSC-EV) 通过调节呼吸道炎症,显示出治疗耐固醇喘的潜力. 本综述探讨了它们的治疗机制和临床翻译挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 肺部病理学 肺部病理学
背景情况:
- 喘是一种慢性呼吸道炎症疾病,对皮质类固醇有不同的反应.
- 类固醇耐药性,特别是在低T助手型2喘中,是一个重大的临床挑战.
- 介酶干细胞 (MSC) 和它们衍生的细胞外囊泡 (MSC-EV) 具有免疫调节特性.
研究的目的:
- 审查MSCs和MSC-EVs抑制喘时呼吸道炎症的机制.
- 突出MSCs和MSC-EVs在耐固醇喘中的治疗潜力.
- 概述MSC基于喘治疗的临床转化挑战和策略.
主要方法:
- 对MSC,MSC-EV和喘的现有文献进行系统审查.
- 针对MSCs和MSC-EVs的免疫调节通路的分析.
- 对基于MSC的喘治疗方法的临床前和临床数据的评估.
主要成果:
- MSCs和MSC-EVs表现出多目标免疫调节以减少呼吸道炎症.
- 这些疗法在喘模型中有望克服皮质类固醇耐药性.
- 临床翻译的关键挑战包括标准化,交付和长期疗效.
结论:
- MSCs和MSC-EVs为喘提供了一种新的治疗途径,特别是耐固醇形式.
- 需要进一步的研究和优化,以促进成功的临床应用.
- 这一审查为开发基于MSC的先进喘治疗提供了基础.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


